Rainier Acquisition Corporation Class A Ordinary Shares

Rainier Acquisition Corporation Class A Ordinary Shares(RNAQ)股票分析

$9.980

0.000 (0.00%)收盘时

Loading chart…
最高
9.980
开盘
9.980
成交量加权均价
9.98
成交量
20.00
市值
—
最低
9.980
成交额
199.60
企业价值/息税折旧摊销前利润(TTM)
0.00

Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.

AI 分析 of Rainier Acquisition Corporation Class A Ordinary Shares (RNAQ)

卖出

Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.

估值指标

Rainier Acquisition Corporation Class A Ordinary Shares(RNAQ)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

5 年均值 P/S
当前P/S
0.00

事件时间线

2026-09-21 (ET)

16:00:00

Nscale Limited Files for IPO, Plans to List on NYSE

RNAQ 常见问题 —— 由 Alphio AI 解答

Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.

Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易